Accuray (ARAY) Competitors

Surmodics (NASDAQ:SRDX) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, institutional ownership and valuation.

Which has stronger earnings & valuation, SRDX or ARAY?

Surmodics has higher earnings, but lower revenue than Accuray.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surmodics	$121.58M	3.67	-$11.54M	-$1.39	-22.45
Accuray	$446.55M	0.31	-$15.55M	N/A	N/A

Do analysts prefer SRDX or ARAY?

Surmodics presently has a consensus price target of $43.00, indicating a potential upside of 37.78%. Given Surmodics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Surmodics is more favorable than Accuray.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Surmodics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Accuray	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the media favor SRDX or ARAY?

In the previous week, Accuray had 2 more articles in the media than Surmodics. MarketBeat recorded 3 mentions for Accuray and 1 mentions for Surmodics. Surmodics' average media sentiment score of 1.89 beat Accuray's score of 1.05 indicating that Surmodics is being referred to more favorably in the media.

Company	Overall Sentiment
Surmodics	Very Positive
Accuray	Positive

Which has more volatility and risk, SRDX or ARAY?

Surmodics has a beta of 1.31, suggesting that its stock price is 31% more volatile than the S&P 500. Comparatively, Accuray has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500.

Is SRDX or ARAY more profitable?

Accuray has a net margin of 0.14% compared to Surmodics' net margin of -16.34%. Accuray's return on equity of 1.43% beat Surmodics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Surmodics	-16.34%	-7.10%	-4.77%
Accuray	0.14%	1.43%	0.14%

Do institutionals & insiders have more ownership in SRDX or ARAY?

96.6% of Surmodics shares are held by institutional investors. Comparatively, 64.1% of Accuray shares are held by institutional investors. 8.9% of Surmodics shares are held by company insiders. Comparatively, 4.2% of Accuray shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Surmodics beats Accuray on 9 of the 14 factors compared between the two stocks.